Works matching IS 15257304 AND DT 2014 AND VI 15 AND IP 6
Results: 20
nab-Paclitaxel for the treatment of advanced squamous non-small-cell lung cancer: a comprehensive update.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Diagnosis and predictive molecular analysis of non-small-cell lung cancer in the Africa-Middle East region: challenges and strategies for improvement.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Prognostic molecular assay might improve identification of patients at risk for recurrence in early-stage non-small-cell lung cancer.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Association between baseline pulmonary status and interstitial lung disease in patients with non-small-cell lung cancer treated with erlotinib--a cohort study.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Occult nodal disease in patients with non-small-cell lung cancer who are suitable for stereotactic ablative body radiation.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Strategies to prevent brain metastasis in high-risk non-small-cell lung cancer: lessons learned from a randomized study of maintenance temozolomide versus observation.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Prognostic significance of genotype and number of metastatic sites in advanced non-small-cell lung cancer.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Emerging Science and Therapies in Non-small-Cell Lung Cancer: Targeting the MET Pathway.
- Published in:
- Clinical Lung Cancer, 2014, v. 15, n. 6, p. 475, doi. 10.1016/j.cllc.2014.08.001
- By:
- Publication type:
- Article
Dramatic Response to Crizotinib in ROS1 Fluorescent In Situ Hybridization- and Immunohistochemistry-Positive Lung Adenocarcinoma: A Case Series.
- Published in:
- Clinical Lung Cancer, 2014, v. 15, n. 6, p. 470, doi. 10.1016/j.cllc.2014.06.004
- By:
- Publication type:
- Article
Occult Nodal Disease in Patients With Non--Small-Cell Lung Cancer Who are Suitable for Stereotactic Ablative Body Radiation.
- Published in:
- Clinical Lung Cancer, 2014, v. 15, n. 6, p. 466, doi. 10.1016/j.cllc.2014.07.006
- By:
- Publication type:
- Article
Correlation Between TS, MTHFR, and ERCC1 Gene Polymorphisms and the Efficacy of Platinum in Combination With Pemetrexed First-Line Chemotherapy in Mesothelioma Patients.
- Published in:
- Clinical Lung Cancer, 2014, v. 15, n. 6, p. 455, doi. 10.1016/j.cllc.2014.06.009
- By:
- Publication type:
- Article
Association Between Baseline Pulmonary Status and Interstitial Lung Disease in Patients With Non--Small-Cell Lung Cancer Treated With Erlotinib--A Cohort Study.
- Published in:
- Clinical Lung Cancer, 2014, v. 15, n. 6, p. 448, doi. 10.1016/j.cllc.2014.06.003
- By:
- Publication type:
- Article
Prognostic Significance of Genotype and Number of Metastatic Sites in Advanced Non--Small-Cell Lung Cancer.
- Published in:
- Clinical Lung Cancer, 2014, v. 15, n. 6, p. 441, doi. 10.1016/j.cllc.2014.06.006
- By:
- Publication type:
- Article
Strategies to Prevent Brain Metastasis in High-Risk Non--Small-Cell Lung Cancer: Lessons Learned From a Randomized Study of Maintenance Temozolomide Versus Observation.
- Published in:
- Clinical Lung Cancer, 2014, v. 15, n. 6, p. 433, doi. 10.1016/j.cllc.2014.06.008
- By:
- Publication type:
- Article
Prognostic Molecular Assay Might Improve Identification of Patients At Risk for Recurrence in Early-Stage Non--Small-Cell Lung Cancer.
- Published in:
- Clinical Lung Cancer, 2014, v. 15, n. 6, p. 426, doi. 10.1016/j.cllc.2014.07.004
- By:
- Publication type:
- Article
Long-Term and Low-Grade Safety Results of a Phase III Study (PARAMOUNT): Maintenance Pemetrexed Plus Best Supportive Care Versus Placebo Plus Best Supportive Care Immediately After Induction Treatment With Pemetrexed Plus Cisplatin for Advanced Nonsquamous Non--Small-Cell Lung Cancer.
- Published in:
- Clinical Lung Cancer, 2014, v. 15, n. 6, p. 418, doi. 10.1016/j.cllc.2014.06.007
- By:
- Publication type:
- Article
Activity of the EGFR-HER2 Dual Inhibitor Afatinib in EGFR-Mutant Lung Cancer Patients With Acquired Resistance to Reversible EGFR Tyrosine Kinase Inhibitors.
- Published in:
- Clinical Lung Cancer, 2014, v. 15, n. 6, p. 411, doi. 10.1016/j.cllc.2014.07.002
- By:
- Publication type:
- Article
Phase II Study of the GI-4000 KRAS Vaccine After Curative Therapy in Patients With Stage I-III Lung Adenocarcinoma Harboring a KRAS G12C, G12D, or G12V Mutation.
- Published in:
- Clinical Lung Cancer, 2014, v. 15, n. 6, p. 405, doi. 10.1016/j.cllc.2014.06.002
- By:
- Publication type:
- Article
Diagnosis and Predictive Molecular Analysis of Non--Small-Cell Lung Cancer in the Africa-Middle East Region: Challenges and Strategies for Improvement.
- Published in:
- Clinical Lung Cancer, 2014, v. 15, n. 6, p. 398, doi. 10.1016/j.cllc.2014.06.005
- By:
- Publication type:
- Article
nab-Paclitaxel for the Treatment of Advanced Squamous Non--Small-Cell Lung Cancer: A Comprehensive Update.
- Published in:
- Clinical Lung Cancer, 2014, v. 15, n. 6, p. 391, doi. 10.1016/j.cllc.2014.07.003
- By:
- Publication type:
- Article